Chimera Investment (NYSE:CIM – Get Free Report) and Omega Healthcare Investors (NYSE:OHI – Get Free Report) are both finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership and valuation.
Volatility and Risk
Chimera Investment has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. Comparatively, Omega Healthcare Investors has a beta of 0.97, indicating that its stock price is 3% less volatile than the S&P 500.
Institutional & Insider Ownership
48.4% of Chimera Investment shares are owned by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are owned by institutional investors. 0.9% of Chimera Investment shares are owned by insiders. Comparatively, 1.4% of Omega Healthcare Investors shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Dividends
Valuation and Earnings
This table compares Chimera Investment and Omega Healthcare Investors’ gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Chimera Investment | $286.07 million | 4.21 | $126.10 million | $1.53 | 9.78 |
Omega Healthcare Investors | $977.40 million | 9.46 | $242.18 million | $1.11 | 33.72 |
Omega Healthcare Investors has higher revenue and earnings than Chimera Investment. Chimera Investment is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent recommendations for Chimera Investment and Omega Healthcare Investors, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Chimera Investment | 0 | 2 | 0 | 0 | 2.00 |
Omega Healthcare Investors | 0 | 8 | 3 | 1 | 2.42 |
Chimera Investment presently has a consensus price target of $16.25, indicating a potential upside of 8.55%. Omega Healthcare Investors has a consensus price target of $33.67, indicating a potential downside of 10.05%. Given Chimera Investment’s higher probable upside, research analysts clearly believe Chimera Investment is more favorable than Omega Healthcare Investors.
Profitability
This table compares Chimera Investment and Omega Healthcare Investors’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Chimera Investment | 25.73% | 7.46% | 1.48% |
Omega Healthcare Investors | 33.52% | 8.68% | 3.57% |
Summary
Omega Healthcare Investors beats Chimera Investment on 12 of the 17 factors compared between the two stocks.
About Chimera Investment
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities. It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.
About Omega Healthcare Investors
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.